We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current 0DTR market cap is 574.43M. The company's latest EPS is PLN 0.0265 and P/E is 252.45.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| PLN (PLN) | PLN (PLN) | PLN (PLN) | PLN (PLN) | PLN (PLN) | |
| Total Revenue | 202.03M | 221.79M | 163.03M | 233.16M | 181.64M |
| Operating Income | -13M | 56.52M | 13.64M | 24.46M | 11.26M |
| Net Income | -126.69M | 33.92M | 2.88M | 1.42M | 2.28M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| PLN (PLN) | PLN (PLN) | PLN (PLN) | PLN (PLN) | PLN (PLN) | |
| Total Assets | 885.08M | 867.11M | 848.13M | 810.33M | 822.22M |
| Total Liabilities | 299.76M | 247.46M | 243.61M | 204.27M | 215.87M |
| Total Equity | 585.32M | 619.65M | 604.51M | 606.06M | 606.36M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| PLN (PLN) | PLN (PLN) | PLN (PLN) | PLN (PLN) | PLN (PLN) | |
| Operating | 46.71M | 41.95M | 5.52M | 56.08M | 39.63M |
| Investing | -53.8M | -4.69M | -4.28M | -29.1M | -36.95M |
| Financing | 6.53M | -22.2M | -14.62M | -26.5M | -8.13M |
| Market Cap | 574.43M |
| Price to Earnings Ratio | 252.45 |
| Price to Sales Ratio | 3.16 |
| Price to Cash Ratio | 148.01 |
| Price to Book Ratio | 0.95 |
| Dividend Yield | - |
| Shares Outstanding | 85.86M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Bioton Sa |
| Address |
ul. staroscinska 5 warsaw 02-516 |
| Website | https://www.bioton.pl |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
